NO20022528D0 - Kjemiske derivater og deres anvendelse som anti- telomerasemiddel - Google Patents

Kjemiske derivater og deres anvendelse som anti- telomerasemiddel

Info

Publication number: NO20022528D0
Authority: NO; Norway
Prior art keywords: chemical derivatives; telomerase agent; telomerase; agent; concerns
Prior art date: 1999-11-29

Application number

NO20022528A

Other languages

English (en)

Other versions

NO20022528L (no

Inventor

Patrick Mailliet

Jean-Francois Riou

Jean-Louis Mergny

Abdelazize Laoui

Francois Lavelle

Odile Patit-Genet

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-29

Filing date

2002-05-28

Publication date

2002-05-28

1999-11-29 Priority claimed from FR9915031A external-priority patent/FR2801588B1/fr

2002-05-28 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2002-05-28 Publication of NO20022528D0 publication Critical patent/NO20022528D0/no

2002-05-28 Publication of NO20022528L publication Critical patent/NO20022528L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

NO20022528A 1999-11-29 2002-05-28 Kjemiske derivater og deres anvendelse som anti- telomerasemiddel NO20022528L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9915031A FR2801588B1 (fr)	1999-11-29	1999-11-29	Derives chimiques et leur application comme agent antitelomerase
FR0010561		2000-08-11
PCT/FR2000/003310 WO2001040218A1 (fr)	1999-11-29	2000-11-27	Derives arylamines et leur application comme agent antitelomerase

Publications (2)

Publication Number	Publication Date
NO20022528D0 true NO20022528D0 (no)	2002-05-28
NO20022528L NO20022528L (no)	2002-05-28

Family

ID=26212577

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022528A NO20022528L (no)	1999-11-29	2002-05-28	Kjemiske derivater og deres anvendelse som anti- telomerasemiddel

Country Status (27)

Country	Link
EP (1)	EP1244650B1 (no)
JP (1)	JP2003515604A (no)
KR (1)	KR20020058043A (no)
CN (1)	CN1402722A (no)
AT (1)	ATE243692T1 (no)
AU (1)	AU2179001A (no)
BG (1)	BG106753A (no)
BR (1)	BR0015992A (no)
CA (1)	CA2392507A1 (no)
CO (1)	CO5251431A1 (no)
CZ (1)	CZ20021849A3 (no)
DE (1)	DE60003583T2 (no)
DK (1)	DK1244650T3 (no)
EA (1)	EA200200616A1 (no)
EE (1)	EE200200263A (no)
ES (1)	ES2202206T3 (no)
HU (1)	HUP0204429A2 (no)
IL (1)	IL149402A0 (no)
MX (1)	MXPA02005276A (no)
NO (1)	NO20022528L (no)
PE (1)	PE20010912A1 (no)
PL (1)	PL355667A1 (no)
PT (1)	PT1244650E (no)
SK (1)	SK7402002A3 (no)
UY (1)	UY26456A1 (no)
WO (1)	WO2001040218A1 (no)
YU (1)	YU38102A (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE396978T1 (de)	1999-10-07	2008-06-15	Amgen Inc	Triazin-kinase-hemmer
JP2003520855A (ja) *	2000-01-28	2003-07-08	アストラゼネカアクチボラグ	化学的化合物
AU3704101A (en)	2000-02-17	2001-08-27	Amgen Inc	Kinase inhibitors
WO2002012194A1 (fr) *	2000-08-08	2002-02-14	Aventis Pharma S.A.	Derives de phenanthridine et leur application comme agents antitelomerases
US7105530B2 (en) *	2000-12-21	2006-09-12	Smithkline Beecham Corporation	Pyrimidineamines as angiogenesis modulators
FR2821355A1 (fr) *	2001-02-23	2002-08-30	Aventis Pharma Sa	Derives chimiques et leur application comme agent antitelomerase
US6887873B2 (en)	2001-03-23	2005-05-03	Aventis Pharma S.A.	Triazine derivatives and their application as antitelomerase agents
FR2822468B1 (fr) *	2001-03-23	2008-06-20	Aventis Pharma Sa	Derives chimiques et leur application comme agent anti-telomerase
CO5380035A1 (es) *	2001-03-23	2004-03-31	Aventis Pharma Sa	Derivados quimicos y su aplicacion como agente antitelomerasa
EP1401833A2 (fr)	2001-05-28	2004-03-31	Aventis Pharma S.A.	Derives chimiques et leur application comme agent antitelomerase
US7115617B2 (en) *	2001-08-22	2006-10-03	Amgen Inc.	Amino-substituted pyrimidinyl derivatives and methods of use
US6939874B2 (en) *	2001-08-22	2005-09-06	Amgen Inc.	Substituted pyrimidinyl derivatives and methods of use
US7169785B2 (en)	2001-09-21	2007-01-30	Reddy Us Therapeutics, Inc.	Methods and compositions of novel triazine compounds
US7132423B2 (en)	2001-09-21	2006-11-07	Reddy Us Therapeutics, Inc.	Methods and compositions of novel triazine compounds
US7173032B2 (en)	2001-09-21	2007-02-06	Reddy Us Therapeutics, Inc.	Methods and compositions of novel triazine compounds
US7112587B2 (en)	2001-09-21	2006-09-26	Reddy Us Therapeutics, Inc.	Methods and compositions of novel triazine compounds
US7163943B2 (en)	2001-09-21	2007-01-16	Reddy Us Therapeutics, Inc.	Methods and compositions of novel triazine compounds
JP2005519876A (ja)	2001-11-27	2005-07-07	メルク　エンド　カムパニー　インコーポレーテッド	２−アミノキノリン化合物
BR0314195A (pt) *	2002-09-10	2005-07-26	Pharmacia Italia Spa	Derivados de piridina substituìda como agentes antitumorais
AU2003275726A1 (en) *	2002-10-24	2004-05-13	Chong Kun Dang Pharmaceutical Corp.	2 - substituted heterocyclic compounds and antitumor composition comprising the same
FR2850970B1 (fr) *	2003-02-07	2006-07-07	Aventis Pharma Sa	Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique
EP1691812A4 (en) *	2003-11-20	2010-01-13	Childrens Hosp Medical Center	GTPASE INHIBITORS AND METHOD OF USE
US7335770B2 (en)	2004-03-24	2008-02-26	Reddy U5 Therapeutics, Inc.	Triazine compounds and their analogs, compositions, and methods
WO2007049057A2 (en) *	2005-10-28	2007-05-03	Iti Scotland Limited	Novel fluorescent dyes and uses thereof
US7713987B2 (en)	2005-12-06	2010-05-11	Rigel Pharmaceuticals, Inc.	Pyrimidine-2,4-diamines and their uses
KR100761869B1 (ko) *	2006-07-07	2007-10-04	김현기	트리아진 유도체 화합물 및 이를 포함하는 암 치료용조성물
EP2046763A2 (en) *	2006-07-31	2009-04-15	Praecis Pharmaceuticals Incorporated	Aurora kinase inhibitors from an encoded small molecule library
JP5325517B2 (ja) *	2007-10-12	2013-10-23	住友化学株式会社	ジベンゾオキセピン化合物の精製方法
JP2009102249A (ja) *	2007-10-22	2009-05-14	Sumitomo Chemical Co Ltd	ジベンゾオキセピン化合物の結晶の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9206768D0 (en) *	1992-03-27	1992-05-13	Jarman Michael	New compounds for use in the treatment of cancer
US5770613A (en) *	1995-09-29	1998-06-23	Geron Corporation	Telomerase inhibitors
JPH1160573A (ja) *	1997-08-22	1999-03-02	Nippon Kayaku Co Ltd	トリアジン誘導体及びテロメラーゼ阻害剤
ATE244241T1 (de) *	1998-02-04	2003-07-15	Univ Texas	Hemmung der menschlichen telomerase durch g- quadruplex interaktionverbindung
DE19812879A1 (de) *	1998-03-24	1999-09-30	Bayer Ag	Substituierte 2,4-Diamino-1,3,5-triazine

2000
- 2000-11-27 CA CA002392507A patent/CA2392507A1/fr not_active Abandoned
- 2000-11-27 MX MXPA02005276A patent/MXPA02005276A/es unknown
- 2000-11-27 YU YU38102A patent/YU38102A/sh unknown
- 2000-11-27 ES ES00985339T patent/ES2202206T3/es not_active Expired - Lifetime
- 2000-11-27 EE EEP200200263A patent/EE200200263A/xx unknown
- 2000-11-27 SK SK740-2002A patent/SK7402002A3/sk unknown
- 2000-11-27 EA EA200200616A patent/EA200200616A1/ru unknown
- 2000-11-27 KR KR1020027006786A patent/KR20020058043A/ko not_active Application Discontinuation
- 2000-11-27 AU AU21790/01A patent/AU2179001A/en not_active Abandoned
- 2000-11-27 BR BR0015992-1A patent/BR0015992A/pt not_active IP Right Cessation
- 2000-11-27 DK DK00985339T patent/DK1244650T3/da active
- 2000-11-27 IL IL14940200A patent/IL149402A0/xx unknown
- 2000-11-27 EP EP00985339A patent/EP1244650B1/fr not_active Expired - Lifetime
- 2000-11-27 DE DE60003583T patent/DE60003583T2/de not_active Expired - Fee Related
- 2000-11-27 JP JP2001541902A patent/JP2003515604A/ja not_active Withdrawn
- 2000-11-27 CZ CZ20021849A patent/CZ20021849A3/cs unknown
- 2000-11-27 CN CN00816440A patent/CN1402722A/zh active Pending
- 2000-11-27 AT AT00985339T patent/ATE243692T1/de not_active IP Right Cessation
- 2000-11-27 PL PL00355667A patent/PL355667A1/xx not_active Application Discontinuation
- 2000-11-27 WO PCT/FR2000/003310 patent/WO2001040218A1/fr not_active Application Discontinuation
- 2000-11-27 HU HU0204429A patent/HUP0204429A2/hu unknown
- 2000-11-27 PT PT00985339T patent/PT1244650E/pt unknown
- 2000-11-28 CO CO00090981A patent/CO5251431A1/es not_active Application Discontinuation
- 2000-11-28 PE PE2000001265A patent/PE20010912A1/es not_active Application Discontinuation
- 2000-11-28 UY UY26456A patent/UY26456A1/es not_active Application Discontinuation
2002
- 2002-05-28 NO NO20022528A patent/NO20022528L/no not_active Application Discontinuation
- 2002-05-29 BG BG106753A patent/BG106753A/bg unknown

Also Published As

Publication number	Publication date
AU2179001A (en)	2001-06-12
EA200200616A1 (ru)	2002-10-31
PL355667A1 (en)	2004-05-04
CZ20021849A3 (cs)	2002-08-14
DE60003583D1 (de)	2003-07-31
EP1244650B1 (fr)	2003-06-25
CO5251431A1 (es)	2003-02-28
BR0015992A (pt)	2002-08-06
HUP0204429A2 (hu)	2003-04-28
SK7402002A3 (en)	2002-11-06
CA2392507A1 (fr)	2001-06-07
WO2001040218A1 (fr)	2001-06-07
EE200200263A (et)	2003-06-16
CN1402722A (zh)	2003-03-12
KR20020058043A (ko)	2002-07-12
MXPA02005276A (es)	2002-11-07
DE60003583T2 (de)	2004-05-13
UY26456A1 (es)	2001-06-29
ATE243692T1 (de)	2003-07-15
PT1244650E (pt)	2003-11-28
IL149402A0 (en)	2002-11-10
YU38102A (sh)	2004-12-31
NO20022528L (no)	2002-05-28
JP2003515604A (ja)	2003-05-07
ES2202206T3 (es)	2004-04-01
DK1244650T3 (da)	2003-10-20
BG106753A (bg)	2003-02-28
PE20010912A1 (es)	2001-09-01
EP1244650A1 (fr)	2002-10-02

Legal Events

Date	Code	Title	Description
2004-11-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20022528D0 (no)	2002-05-28	Kjemiske derivater og deres anvendelse som anti- telomerasemiddel
ATE302775T1 (de)	2005-09-15	Carbolinderivate
WO2002096903A3 (fr)	2003-04-17	Derives chimiques et leur application comme agent antitelomerase
DK1204649T3 (da)	2007-12-03	Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20060971L (no)	2006-05-02	Pyridazinderivater og deres anvendelse som terapeutiske midler
ECSP034774A (es)	2003-12-24	Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es)	2003-12-24	Pirazolopirimmidinas como agentes terapeuticos
NO20042635L (no)	2004-06-23	5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
ATE346067T1 (de)	2006-12-15	Carbolinderivate
ATE231872T1 (de)	2003-02-15	Thiazolopyrimidinderivate
MXPA03002911A (es)	2003-09-10	Compuestos quimicos.
NO20025150D0 (no)	2002-10-25	2-acylindolderivater og deres anvendelse som antitumormidler
MXPA02012076A (es)	2003-06-06	Compuestos quimicos.
MXPA02012659A (es)	2003-09-22	Derivados de pirazindiona condensados.
SE0101932D0 (sv)	2001-05-31	Pharmaceutical combinations
WO2002070469A3 (en)	2004-03-04	Selective pde3b inhibitors and use of the same in therapy
SE9904377D0 (sv)	1999-12-01	Pharmaceutical combinations
DE60112960D1 (de)	2005-09-29	Kondensierte pyridoindolderivate
MY130957A (en)	2007-07-31	Triazine derivatives and their application as antitelomerase agents
ATE368649T1 (de)	2007-08-15	Cyanoguanidin prodrugs
MXPA03003971A (es)	2004-02-12	Derivados de indol como inhibidores de pde5.
MXPA02012472A (es)	2004-01-26	Compuestos quimicos.
DE60213798D1 (de)	2006-09-21	Carbolinderivate als pdev inhibitoren
WO2002039958A3 (en)	2002-09-06	Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
MXPA04005226A (es)	2004-10-11	1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion.